Christopher Ryan Sullivan
Net Worth
Last updated:
What is Christopher Ryan Sullivan net worth?
The estimated net worth of Mr. Christopher Ryan Sullivan is at least $23,584 as of 10 Dec 2020. He owns shares worth $23,584 as insider in Cerecor Inc..
What stocks does Christopher Ryan Sullivan currently own?
As insider, Mr. Christopher Ryan Sullivan owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Cerecor Inc. (CERC) | Chief Accounting Officer & Principal Accounting Officer | 8,049 | $2.93 | $23,584 |
What does Cerecor Inc. do?
Cerecor Inc., a biopharmaceutical company, focuses on development and commercialization of treatments for rare pediatric and orphan diseases. It develop therapies for the treatment of inherited metabolic disorders, such as CERC-801 and CERC-802, which completed the phase I clinical trial; and CERC-803. The company is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of autoimmune inflammatory diseases, such as adult onset stills disease and multiple myeloma; CERC-006, a dual mTOR inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody for the treatment of Pediatric-onset Crohn's diseases. In addition, it develops CERC-913, a protide nucleotide for the treatment of mitochondrial disorder; CERC-005, a monoclonal antibody to treat rare auto-inflammatory diseases; CERC-301 for the treatment of symptomatic Orthostatic Hypotension; and CERC-406 for the treatment of Parkinson's disease. Further, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.
Christopher Ryan Sullivan insider trading
Cerecor key executives
Cerecor Inc. executives and other stock owners filed with the SEC:
- Dr. Barbara S. Slusher Founder and Member of Scientific Advisory Board
- Dr. Garry A. Neil (71) Chief Scientific Officer
- Dr. H. Jeffery Wilkins M.D. (63) Chief Medical Officer
- Dr. Lisa Hegg Vice President of R&D Programs and Project Management
- Dr. Solomon H. Snyder Founder and Chairman of Scientific Advisory Board
- Dr. Younok Dumortier Shin M.B.A., Ph.D. Chief Technology Officer
- Mr. Christopher Ryan Sullivan Chief Accounting Officer & Principal Accounting Officer
- Mr. James Archie Harrell Jr. Chief Commercial Officer
- Mr. Michael F. Cola (65) Chief Executive Officer, Pres & Director
- Mr. Schond L. Greenway Chief Financial Officer, Principal Financial Officer & Treasurer